Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back
View Video

2023 PRIM&R Annual Conference

Emerging Research Challenges and Breaking Issues

[IN-PERSON/LIVESTREAMED] PRIMR23 Welcome Remarks and Opening General Session: What Keeps You Up at Night: Future Frontiers in Research

Monday, December 4, 2023
8:30 AM – 10:00 AM ET
Location: Hall E
Livestreaming Session Icon Crossover Thought Leader Series CIP Accredited
This general session will be held in-person, livestreamed for the Virtual Meeting, and recorded for on-demand access by attendees registered for PRIMR23 on this day.

PRIMR23 will begin with welcome remarks from the PRIMR23 Conference Planning Committee Co-Chairs, followed by a presentation from PRIM&R's new Executive Director, Ivy Tillman, EdD, MS, CCRC, CIP.

Opening General Session Descriptor: What will the research landscape look like in 10-20 years? During this moderated session, a diverse panel of national experts in clinical trials and drug development, artificial intelligence, nonhuman primate research, scientific workforce development, and more will provide their perspectives on the research enterprise trajectory and what challenges that may lie ahead for the ethics and oversight community.